PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways.

Dendritic cells (DCs) play an important role in initiating and maintaining primary immune responses. However, mechanisms involved in the resolution of these responses are elusive. We analyzed the effects of 15d-PGJ2 and the synthetic peroxisome proliferator-activated receptor (PPAR)-gamma ligand troglitazone (TGZ) on the immunogenicity of human monocyte-derived DCs upon stimulation with toll-like receptor (TLR) ligands. Activation of PPAR-gamma resulted in a reduced stimulation of DCs via the TLR ligands 2, 3, 4, and 7, characterized by down-regulation of costimulatory and adhesion molecules and reduced secretion of cytokines and chemokines involved in T-lymphocyte activation and recruitment. MCP-1 (monocyte chemotactic protein-1) production was increased due to PPAR-gamma activation. Furthermore, TGZ-treated DCs showed a significantly reduced capacity to stimulate T-cell proliferation, emphasizing the inhibitory effect of PPAR-gamma activation on TLR-induced DC maturation. Western blot analyses revealed that these inhibitory effects on TLR-induced DC activation were mediated via inhibition of the NF-kappaB and mitogen-activated protein (MAP) kinase pathways while not affecting the PI3 kinase/Akt signaling. Our data demonstrate that inhibition of the MAP kinase and NF-kappaB pathways is critically involved in the regulation of TLR and PPAR-gamma-mediated signaling in DCs.

[1]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[2]  O. Schoor,et al.  Effects of Imatinib on Monocyte-Derived Dendritic Cells Are Mediated by Inhibition of Nuclear Factor-κB and Akt Signaling Pathways , 2005, Clinical Cancer Research.

[3]  S. Gordon,et al.  Ligand recognition by antigen-presenting cell C-type lectin receptors , 2004, Current Opinion in Immunology.

[4]  T. Geijtenbeek,et al.  Distinct functions of DC‐SIGN and its homologues L‐SIGN (DC‐SIGNR) and mSIGNR1 in pathogen recognition and immune regulation , 2004, Cellular microbiology.

[5]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[6]  L. Nagy,et al.  Activation of PPARgamma specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. , 2004, Immunity.

[7]  M. Greenblatt,et al.  A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria , 2004, Science.

[8]  T. Brümmendorf,et al.  Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells. , 2004, Blood.

[9]  T. Lawrence,et al.  Inducible cyclooxygenase‐derived 15deoxy Δ 12‐14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  K. Lauber,et al.  Cyclopentenone Prostaglandins Induce Lymphocyte Apoptosis by Activating the Mitochondrial Apoptosis Pathway Independent of External Death Receptor Signaling 1 , 2003, The Journal of Immunology.

[11]  S. Akira,et al.  TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway , 2003, Nature Immunology.

[12]  Daniel R. Caffrey,et al.  LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.

[13]  Jiahuai Han,et al.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.

[14]  H. Hammad,et al.  Peroxisome Proliferator-Activated Receptor γ Inhibits the Migration of Dendritic Cells: Consequences for the Immune Response1 , 2003, The Journal of Immunology.

[15]  D. Boffa,et al.  Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes. , 2003, Cellular immunology.

[16]  Ryan M. O’Connell,et al.  Toll-Like Receptor 3 Mediates a More Potent Antiviral Response Than Toll-Like Receptor 41 , 2003, The Journal of Immunology.

[17]  W. Brugger,et al.  Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. , 2002, Experimental hematology.

[18]  W. Brugger,et al.  Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor γ1 , 2002, The Journal of Immunology.

[19]  Jae-Geun Yoon,et al.  Role of Mitogen-Activated Protein Kinases in CpG DNA-Mediated IL-10 and IL-12 Production: Central Role of Extracellular Signal-Regulated Kinase in the Negative Feedback Loop of the CpG DNA-Mediated Th1 Response1 , 2002, The Journal of Immunology.

[20]  R. Phipps,et al.  Human B Lymphocytes and B Lymphomas Express PPAR-γ and Are Killed by PPAR-γ Agonists , 2002 .

[21]  Ye Zheng,et al.  Dendritic Cell Development and Survival Require Distinct NF-κB Subunits , 2002 .

[22]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[23]  R. Darnell,et al.  Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells , 2001, Nature Immunology.

[24]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[25]  Meredith O'Keeffe,et al.  C-Rel Regulates Interleukin 12 P70 Expression in Cd8+ Dendritic Cells by Specifically Inducing p35 Gene Transcription , 2001, The Journal of experimental medicine.

[26]  Philippe Gosset,et al.  Peroxisome proliferator‐activated receptor γ  activators affect the maturation of human monocyte‐derived dendritic cells , 2001 .

[27]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[28]  R. Phipps,et al.  The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis , 2001, European journal of immunology.

[29]  R. Ulevitch,et al.  Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. , 2001, Biochimica et biophysica acta.

[30]  E. Kiss-Toth,et al.  Evidence for an Accessory Protein Function for Toll-Like Receptor 1 in Anti-Bacterial Responses1 , 2000, The Journal of Immunology.

[31]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Ulevitch,et al.  Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. , 2000, European cytokine network.

[33]  S. Akira,et al.  Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88 , 2000, Current Biology.

[34]  S. Akira,et al.  Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 , 2000, The Journal of experimental medicine.

[35]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[36]  B. Kelsall,et al.  Selective Suppression of IL-12 Production by Chemoattractants , 2000, The Journal of Immunology.

[37]  R. Andreesen,et al.  Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells. , 2000, Biochemical and biophysical research communications.

[38]  S. Akira,et al.  Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway1 , 2000, The Journal of Immunology.

[39]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[40]  A. D'amico,et al.  RelB Is Essential for the Development of Myeloid-Related CD8α− Dendritic Cells but Not of Lymphoid-Related CD8α+ Dendritic Cells , 1998 .

[41]  C. Janeway,et al.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. , 1998, Molecular cell.

[42]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[43]  S. Saccani,et al.  The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6) , 1998, The Journal of experimental medicine.

[44]  F. Martinon,et al.  MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.

[45]  D. Carbone,et al.  Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. , 1998, Journal of immunology.

[46]  Z. Cao,et al.  MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. , 1997, Immunity.

[47]  P. Feng,et al.  IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. , 1997, Science.

[48]  G. Thomas,et al.  Nuclear localization of RelB is associated with effective antigen-presenting cell function. , 1997, Journal of immunology.

[49]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[50]  A. Strasser,et al.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.

[51]  D. Lo,et al.  Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.

[52]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[53]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[54]  安冨 素子.  Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response , 2005 .

[55]  S. Wesselborg,et al.  Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses. , 2003, Critical reviews in immunology.

[56]  Chen Dong,et al.  MAP kinases in the immune response. , 2002, Annual review of immunology.

[57]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[58]  R. Phipps,et al.  Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. , 2002, Clinical immunology.

[59]  Ye Zheng,et al.  Dendritic cell development and survival require distinct NF-kappaB subunits. , 2002, Immunity.

[60]  R. Evans,et al.  PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.

[61]  W. Heath,et al.  Cross-presentation, dendritic cells, tolerance and immunity. , 2001, Annual review of immunology.

[62]  B Staels,et al.  Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. , 2001, European journal of immunology.

[63]  S. Akira,et al.  Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. , 2000, International immunology.

[64]  E. Bröcker,et al.  Differential expression of Rel/NF-κB and octamer factors is a hallmark of the generation and maturation of dendritic cells , 2000 .

[65]  J. Padilla,et al.  Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells. , 2000, Journal of immunology.

[66]  E. Bröcker,et al.  Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. , 2000, Blood.

[67]  A. D'amico,et al.  RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. , 1998, Immunity.

[68]  J. Blenis,et al.  Kinase-Mitogen-Activated Protein Kinase Signal-Regulated Modulation of Extracellular Distinct Th Responses via Differential Agonists Instruct Dendritic Cells to Induce Cutting Edge: Different Toll-Like Receptor , 2022 .